Dr. Esra Ataman graduated from Ege University Faculty of Medicine in 2005 and completed her residency training in Medical Genetics at the Department of Medical Genetics, Ege University Faculty of Medicine, in 2010. She completed her doctoral studies in Molecular Medicine at the Institute of Health Sciences, Dokuz Eylül University. Her residency thesis investigated matrix metalloproteinase (MMP2 and MMP9) gene polymorphisms in spontaneous abortion specimens, while her doctoral research focused on the role of genetic alterations in familial cases of Multiple Sclerosis.
Dr. Ataman began her professional career as a research assistant in the Department of General Surgery at Akdeniz University Faculty of Medicine and subsequently worked as a research assistant in the Department of Medical Genetics at Ege University Faculty of Medicine. After completing her compulsory service at Kanuni Sultan Süleyman Training and Research Hospital, she worked as a specialist physician and lecturer in the Department of Medical Genetics and the Institute of Oncology at Dokuz Eylül University Faculty of Medicine. Throughout her academic career, she provided undergraduate, graduate, and doctoral-level education in basic oncology and medical genetics.
Her areas of interest include prenatal diagnosis, clinical genetics, rare diseases, neurogenetic disorders, cancer genetics, molecular genetics, cytogenetics, epilepsy genetics, developmental anomalies, and inherited metabolic diseases. She has served as a researcher in numerous national and international research projects on a wide range of topics, including thalassemia, CHARGE syndrome, Alström syndrome, Alzheimer’s disease, obesity, infertility, spontaneous abortions, epilepsy, cortical developmental disorders, and genetic alterations in patients undergoing peritoneal dialysis.
Dr. Ataman has authored numerous original research articles published in international journals indexed in SCI and SCI-Expanded, presented papers at national and international congresses, and contributed chapters to books on medical genetics. Her academic publications cover a broad range of topics, including prenatal diagnosis, chromosomal abnormalities, CHARGE syndrome, PAX6, PCDH19, Alström syndrome, epilepsy genetics, cortical developmental disorders, peritoneal dialysis, and molecular genetics. She also serves as a peer reviewer for international scientific journals.
In 2009, she received the Best Clinical Oncology Hypothesis Award at the 5th National Oncology Research Workshop for her study entitled “The Association of Estrogen Receptor Beta Gene A1730G Polymorphism with Breast Cancer Susceptibility and Prognosis in the Turkish Population.”
Dr. Esra Ataman is a member of the Turkish Society of Medical Genetics, the Ege Perinatology Society, the American Society of Human Genetics (ASHG), and the European Society of Human Genetics (ESHG). She continues her professional work in the diagnosis of genetic diseases, genetic counseling, prenatal and postnatal genetic evaluation, and molecular diagnostic processes.
As of 2026, she serves as the Medical Director of Intergen Antalya.